Should I buy or sell Ingevity stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" NGVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NGVT, but not buy additional shares or sell existing shares. View NGVT analyst ratings or view top-rated stocks .

What is Ingevity's stock price target for 2024?

4 brokerages have issued 12-month price targets for Ingevity's stock. Their NGVT share price targets range from $43.00 to $53.00. On average, they predict the company's share price to reach $48.75 in the next year. This suggests a possible upside of 12.1% from the stock's current price. View analysts price targets for NGVT or view top-rated stocks among Wall Street analysts .

How have NGVT shares performed in 2024?

Ingevity's stock was trading at $47.22 at the beginning of the year. Since then, NGVT stock has decreased by 7.9% and is now trading at $43.50. View the best growth stocks for 2024 here .

When is Ingevity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our NGVT earnings forecast .

How were Ingevity's earnings last quarter?

Ingevity Co. (NYSE:NGVT) released its earnings results on Wednesday, February, 21st. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.34. The business earned $371.70 million during the quarter, compared to analyst estimates of $336.74 million. Ingevity had a negative net margin of 0.32% and a positive trailing twelve-month return on equity of 20.75%. The business's revenue for the quarter was down 3.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.57 earnings per share.

What ETFs hold Ingevity's stock?

ETFs with the largest weight of Ingevity (NYSE:NGVT) stock in their portfolio include Invesco S&P SmallCap Materials ETF (PSCM) , Putnam BioRevolution ETF (SYNB) , ProShares Smart Materials ETF (TINT) and Thrivent Small-Mid Cap ESG ETF (TSME) . Avantis U.S. Small Cap Equity ETF (AVSC) .

What guidance has Ingevity issued on next quarter's earnings?

Ingevity updated its FY 2024 earnings guidance on Wednesday, February, 21st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.4 billion-$1.6 billion, compared to the consensus revenue estimate of $1.5 billion.

What is John Fortson's approval rating as Ingevity's CEO?

2 employees have rated Ingevity Chief Executive Officer John Fortson on Glassdoor.com . John Fortson has an approval rating of 100% among the company's employees. This puts John Fortson in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Pfizer (PFE) , AbbVie (ABBV) , General Electric (GE) , Verizon Communications (VZ) , WestRock (WRK) , Abbott Laboratories (ABT) , Boeing (BA) , Costco Wholesale (COST) , Dominion Energy (D) and Johnson & Johnson (JNJ) .

Who are Ingevity's major shareholders?

Ingevity's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Salem Investment Counselors Inc. (0.28%) and Moody National Bank Trust Division (0.06%). Insiders that own company stock include Erik Spencer Ripple, Phillip John Platt, Richard Allen White Jr and Stuart Edward Jr Woodcock . View institutional ownership trends .

How do I buy shares of Ingevity?

Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:NGVT

Ingevity (NGVT) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free NGVT Stock Alerts

$43.50

-0.29 (-0.66%)

(As of 04/18/2024 ET)

Compare

Today's Range: $43.15
▼
$44.34
50-Day Range: $43.50
▼
$49.17
52-Week Range: $36.66
▼
$72.76

Volume: 158,709 shs
Average Volume: 222,083 shs
Market Capitalization: $1.58 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $48.75

Get Ingevity alerts:

Ingevity MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 12.1% Upside
$48.75 Price Target
Short Interest: Healthy
1.93% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.97
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 40.82%
From $3.65 to $5.14 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.56 out of 5 stars

Basic Materials Sector

109th out of 174 stocks

Chemicals & Allied Products Industry

8th out of 14 stocks

2.0

Analyst's Opinion

Consensus Rating
Ingevity has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Ingevity has only been the subject of 1 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
1.93% of the float of Ingevity has been sold short.
Short Interest Ratio / Days to Cover
Ingevity has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Ingevity has recently decreased by 10.03%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Ingevity does not currently pay a dividend.
Dividend Growth
Ingevity does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NGVT.

3.3

News and Social Media Coverage

News Sentiment
Ingevity has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Basic Materials companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Ingevity this week, compared to 2 articles on an average week.
Search Interest
1 people have searched for NGVT on MarketBeat in the last 30 days.
MarketBeat Follows
Only 3 people have added Ingevity to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Ingevity insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.10% of the stock of Ingevity is held by insiders.
Percentage Held by Institutions
91.59% of the stock of Ingevity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Ingevity are expected to grow by 40.82% in the coming year, from $3.65 to $5.14 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Ingevity is -197.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Ingevity is -197.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Ingevity has a P/B Ratio of 2.50. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About Ingevity Stock (NYSE:NGVT)

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, paper chemicals, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts and components manufacturers through sales representatives and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

NGVT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NGVT Stock News Headlines

April 18, 2024 | businesswire.com

Ingevity announces dates for first-quarter 2024 earnings release and webcast

April 13, 2024 | americanbankingnews.com

Ingevity Co. (NYSE:NGVT) Receives Average Rating of "Hold" from Analysts

April 18, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

April 13, 2024 | americanbankingnews.com

Ingevity (NYSE:NGVT) Stock Crosses Below 50 Day Moving Average of $46.15

March 28, 2024 | finance.yahoo.com

At US$48.44, Is Ingevity Corporation (NYSE:NGVT) Worth Looking At Closely?

March 24, 2024 | fool.com

Ingevity (NYSE: NGVT)

March 4, 2024 | prnewswire.com

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Ingevity Corporation (NYSE: NGVT)

February 27, 2024 | finance.yahoo.com

NGVT Jun 2024 50.000 call

April 18, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

February 27, 2024 | finance.yahoo.com

NGVT Apr 2024 45.000 call

February 23, 2024 | realmoney.thestreet.com

Ingevity price target raised by $7 at Wells Fargo, here's why

February 23, 2024 | markets.businessinsider.com

Ingevity: Hold Rating Amidst Transition and Macroeconomic Uncertainties

February 23, 2024 | msn.com

Ingevity (NGVT) Price Target Increased by 5.98% to 56.83

February 23, 2024 | finance.yahoo.com

Ingevity Corporation (NYSE:NGVT) Q4 2023 Earnings Call Transcript

February 22, 2024 | seekingalpha.com

Ingevity Corporation 2023 Q4 - Results - Earnings Call Presentation

February 22, 2024 | markets.businessinsider.com

Ingevity Hold Rating Maintained Amidst Cost Challenges and Transitional Outlook for 2024

February 21, 2024 | finance.yahoo.com

Ingevity (NGVT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

February 21, 2024 | finance.yahoo.com

Ingevity Corp (NGVT) Faces Restructuring Challenges Despite Revenue Growth

February 21, 2024 | finance.yahoo.com

Ingevity (NGVT) Q4 Earnings and Revenues Beat Estimates

February 21, 2024 | markets.businessinsider.com

Ingevity earnings: here's what Wall Street expects

February 21, 2024 | businesswire.com

Ingevity reports fourth quarter and full year 2023 financial results

February 20, 2024 | benzinga.com

Ingevity's Earnings Outlook

February 19, 2024 | finance.yahoo.com

Wall Street's Insights Into Key Metrics Ahead of Ingevity (NGVT) Q4 Earnings

February 12, 2024 | finance.yahoo.com

Chuck Royce's Strategic Moves: Spotlight on Advance Auto Parts Inc's 0.38% Portfolio Addition

February 8, 2024 | wsj.com

Ingevity Corp.

February 8, 2024 | finance.yahoo.com

Ingevity announces dates for fourth-quarter and full year 2023 earnings release and webcast

January 25, 2024 | finance.yahoo.com

NGVT: Raising target price to $40.00

See More Headlines

Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/21/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/01/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Basic Materials
Industry: Chemicals & allied products
Sub-Industry: N/A
Current Symbol: NYSE:NGVT
Previous Symbol: NASDAQ:NGVT
CUSIP: N/A
CIK: 1653477
Web: www.ingevity.com
Phone: (843) 740-2300
Fax: 843-740-8165
Employees: 1,700
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $48.75
High Stock Price Target: $53.00
Low Stock Price Target: $43.00
Potential Upside/Downside: +12.1%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.22)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 11.92
P/E Growth: N/A
Net Income: N/A
Net Margins: -0.32%
Pretax Margin: -0.60%
Return on Equity: 20.75%
Return on Assets: 5.27%

Debt

Debt-to-Equity Ratio: 2.19
Current Ratio: 1.81
Quick Ratio: 0.96

Sales & Book Value

Annual Sales: $1.69 billion
Price / Sales: 0.93
Cash Flow: $7.23 per share
Price / Cash Flow: 6.02
Book Value: $17.43 per share
Price / Book: 2.50

Miscellaneous

Outstanding Shares: 36,280,000
Free Float: 35,882,000
Market Cap: $1.58 billion
Optionable: Optionable
Beta: 1.85

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. John C. Fortson (Age 57)
President, CEO & Director
Comp: $1.29M
Ms. Mary Dean Hall (Age 66)
Executive VP & CFO
Comp: $658.77k
Ms. Stacy Lancaster Cozad (Age 53)
Executive VP, General Counsel & Secretary
Comp: $615.75k
Mr. Stuart Edward Woodcock Jr. (Age 58)
Executive VP & President of Performance Materials
Comp: $823.8k
Mr. Richard A. White Jr. (Age 61)
Senior VP & President of Performance Chemicals
Comp: $575.57k
Mr. Phillip John Platt (Age 43)
VP, Chief Accounting Officer & Business Transformation Lead
John E. Nypaver Jr.
VP of Investor Relations & Treasurer
Caroline Monahan
Director of Communications
Ms. Christine Stunyo (Age 45)
Senior VP & Chief Human Resources Officer
Mr. Steven P. Hulme (Age 55)
Senior VP & President of Advanced Polymer Technologies

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

NGVT Stock Analysis - Frequently Asked Questions

Should I buy or sell Ingevity stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" NGVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NGVT, but not buy additional shares or sell existing shares.
View NGVT analyst ratings or view top-rated stocks.
What is Ingevity's stock price target for 2024?: 4 brokerages have issued 12-month price targets for Ingevity's stock. Their NGVT share price targets range from $43.00 to $53.00. On average, they predict the company's share price to reach $48.75 in the next year. This suggests a possible upside of 12.1% from the stock's current price.
View analysts price targets for NGVT or view top-rated stocks among Wall Street analysts.
How have NGVT shares performed in 2024?: Ingevity's stock was trading at $47.22 at the beginning of the year. Since then, NGVT stock has decreased by 7.9% and is now trading at $43.50.
View the best growth stocks for 2024 here.
When is Ingevity's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our NGVT earnings forecast.
How were Ingevity's earnings last quarter?: Ingevity Co. (NYSE:NGVT) released its earnings results on Wednesday, February, 21st. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.34. The business earned $371.70 million during the quarter, compared to analyst estimates of $336.74 million. Ingevity had a negative net margin of 0.32% and a positive trailing twelve-month return on equity of 20.75%. The business's revenue for the quarter was down 3.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.57 earnings per share.
What ETFs hold Ingevity's stock?: ETFs with the largest weight of Ingevity (NYSE:NGVT) stock in their portfolio include Invesco S&P SmallCap Materials ETF (PSCM), Putnam BioRevolution ETF (SYNB), ProShares Smart Materials ETF (TINT) and Thrivent Small-Mid Cap ESG ETF (TSME).Avantis U.S. Small Cap Equity ETF (AVSC).

What guidance has Ingevity issued on next quarter's earnings?: Ingevity updated its FY 2024 earnings guidance on Wednesday, February, 21st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.4 billion-$1.6 billion, compared to the consensus revenue estimate of $1.5 billion.
What is John Fortson's approval rating as Ingevity's CEO?: 2 employees have rated Ingevity Chief Executive Officer John Fortson on Glassdoor.com. John Fortson has an approval rating of 100% among the company's employees. This puts John Fortson in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Ingevity own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), WestRock (WRK), Abbott Laboratories (ABT), Boeing (BA), Costco Wholesale (COST), Dominion Energy (D) and Johnson & Johnson (JNJ).
Who are Ingevity's major shareholders?: Ingevity's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Salem Investment Counselors Inc. (0.28%) and Moody National Bank Trust Division (0.06%). Insiders that own company stock include Erik Spencer Ripple, Phillip John Platt, Richard Allen White Jr and Stuart Edward Jr Woodcock.
View institutional ownership trends.
How do I buy shares of Ingevity?: Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NGVT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Ingevity (NGVT) Stock Price, News & Analysis

Ingevity MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Ingevity Stock (NYSE:NGVT)

NGVT Stock Price History

NGVT Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

NGVT Stock Analysis - Frequently Asked Questions

Overall MarketRank^™